Test Code LAB3331 1,3-Beta-D-Glucan (Fungitell), Serum
Specimen Required
Container/Tube: Serum gel (red top tube is not acceptable)
Specimen Volume: 1 mL
Collection Instructions:
1. Avoid exposure of specimen to atmosphere to prevent environmental contamination of the sample.
2. Centrifuge and send entire specimen in original collection tube. Do not aliquot or open tube.
Secondary ID
604094Useful For
Aiding in the diagnosis of invasive fungal infections caused by various fungi, including Aspergillus species, Fusarium species, Candida species, and Pneumocystis jirovecii, among others
Method Name
Protease Zymogen-Based Colorimetric Assay
Reporting Name
(1, 3) Beta-D-Glucan (Fungitell), SSpecimen Type
Serum SSTSpecimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum SST | Refrigerated (preferred) | 14 days | SERUM GEL TUBE |
Frozen | 30 days | SERUM GEL TUBE |
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | Reject |
Gross icterus | Reject |
Finger/heel sticks | Reject |
Reference Values
Fungitell quantitative value:
<60 pg/mL
Fungitell qualitative result:
Negative
Reference values apply to all ages.
Cautions
(1, 3)-Beta-D-glucan (BDG) is not present in the Mucorales (eg, Lichtheimia, Mucor, Rhizopus), Cryptococcus species, or Blastomyces species. Therefore, invasive fungal infection with any of these agents will lead to a negative BDG result.
BDG results should be interpreted alongside other diagnostic testing results, including culture, molecular assays, or serology.
False-positive BDG results have been documented in patients having undergone recent hemodialysis, those that have received certain fractionated blood products (eg, albumin, immunoglobulins), and those who have had exposure to high amounts of glucan-containing gauze during surgery. BDG levels normalize approximately 3 to 4 days following these events.
Single time-point testing with the BDG assay is associated with limited clinical sensitivity and specificity. Serial testing, at least 2 times per week, is associated with higher diagnostic odds ratio (DOR 112) for the presence of an invasive fungal infection in an at-risk patient compared to single time-point positive result (DOR 16).
The BDG assay does not identify or indicate the presence of a specific fungal organism.
Serial testing to document BDG levels may be used to monitor disease progression and response to therapy; however, data on the clinical utility and accuracy of this practice is limited.
Day(s) Performed
Monday through Friday, Sunday
Report Available
1 to 2 daysPerforming Laboratory

Test Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
87449
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
SFUNG | (1, 3) Beta-D-Glucan (Fungitell), S | 42176-8 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
603615 | Fungitell Quantitative Value | 42176-8 |
603616 | Fungitell Qualitative Result | 93812-6 |
NY State Approved
YesForms
If not ordering electronically, complete, print, and send 1 of the following forms with the specimen:
-General Request (T239)
-Microbiology Test Request (T244)